Custom Product Briefs

Public View

Whether you're running low on time or have an upcoming value analysis meeting, ECRI Institute's on-demand Product Brief Service makes it easy for hospitals and health plans to submit questions about new brand-name healthcare technologies.

Get the Answers You Need

Take the stress out of your search for answers on brand-name drugs and devices. In a customized 3- to 6-page ultra-rapid review, we provide a product overview, probe manufacturer claims, list relevant clinical studies and regulatory information, and offer our independent, bottom-line recommendations to answer your questions, allowing you to separate the hype from the evidence. All completed Product Briefs are added to our database.

This service is available as part of our Health Technology Assessment Information Service.

 Make quicker, evidence-based decisions

​In addition to an executive summary, you get a product overview and information on:

  • Purported benefits and advantages. See manufacturer claims on a brand-name drug or device.
  • Regulatory status. Has the Food and Drug Administration addressed the need for this type of intervention?
  • Clinical literature. What does the clinical literature say?
  • Safety. Have there been any reported safety issues related to this product?
  • ECRI Institute bottom-line opinions. Our experts offer unbiased, evidence-based guidance on how to proceed with a specific technology.

Depending on the technology and the available evidence, we also offer information on current diagnostics, current treatments, and point of testing.

 Sample Product Briefs

 

 

Rebel Platinum Chromium Coronary Stent System (Boston Scientific Corp.) for Improving Coronary Luminal Diameter in Patients with De Novo Lesionshttps://www.ecri.org/components/ProductBriefs/Pages/23427.aspxRebel Platinum Chromium Coronary Stent System (Boston Scientific Corp.) for Improving Coronary Luminal Diameter in Patients with De Novo Lesions10/12/2015 12:00:00 AM​The Rebel™ Stent System is a bare metal stent (BMS) system intended to treat de novo stenotic coronary arteries. The product includes the platinum chromium alloy BMS and delivery system components usable in either monorail or over-the-wire configurations.